Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. (NBIX) — Form 144: Proposed sale of shares
About this filing
Neurocrine Biosciences, Inc. (NBIX) filed Form 144 (proposed sale of shares) with the SEC on Nov 2, 2026. Form 144 is notice that an insider or affiliate plans to sell shares.
Key facts
- Seller
- GEORGE MORROW
- Relationship
- Director
- Shares to sell
- 14,700
- Market value
- $2,147,670.00
- Approximate sale date
- Nov 2, 2026
- Broker
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Acquired
- Nov 2, 2026 · Exercise of Stock Options
Rule 10b5-1 plan · adopted May 26, 2026
Remarks
- The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
More NBIX filings
- 4
Filed Nov 19, 2026
- 144
Filed Nov 17, 2026
- 144
Filed Nov 10, 2026
- 4
Filed Nov 5, 2026
- 4
Filed Nov 3, 2026
- 4
Filed Nov 3, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.